These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3112985)

  • 1. Acivicin reduces tumor growth during total parenteral nutrition (TPN).
    Chance WT; Cao L; Nelson JL; Foley-Nelson T; Fischer JE
    Surgery; 1987 Aug; 102(2):386-94. PubMed ID: 3112985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response of tumor and host to hyperalimentation and antiglutamine treatments.
    Chance WT; Cao LQ; Fischer JE
    JPEN J Parenter Enteral Nutr; 1990; 14(2):122-8. PubMed ID: 2112618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin and acivicin improve host nutrition and prevent tumor growth during total parenteral nutrition.
    Chance WT; Cao L; Fischer JE
    Ann Surg; 1988 Oct; 208(4):524-31. PubMed ID: 3140745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clenbuterol plus acivicin decrease tumor growth and increase muscle mass in rats maintained on total parenteral nutrition.
    Chance WT; Cao L; Zhang FS; Fischer JE
    Am J Surg; 1991 Jan; 161(1):51-6. PubMed ID: 1899011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged survival by tumor-bearing rats treated with acivicin and total parenteral nutrition.
    Chance WT; Cao LQ; Fischer JE
    J Natl Cancer Inst; 1990 Mar; 82(5):432-4. PubMed ID: 2106035
    [No Abstract]   [Full Text] [Related]  

  • 6. Reduction of tumor growth following treatment with a glutamine antimetabolite.
    Chance WT; Cao L; Kim MW; Nelson JL; Fischer JE
    Life Sci; 1988; 42(1):87-94. PubMed ID: 3336272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of tumor and parenteral nutrition on jejunal mucosal polyamines.
    Chance WT; Noguchi Y; Zhang X; Hasselgren PO; Fischer JE
    Nutr Cancer; 1995; 23(1):23-32. PubMed ID: 7739912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multi-enzyme-targeted chemotherapy by acivicin and actinomycin.
    Weber G; Prajda N; Lui MS; Denton JE; Aoki T; Sebolt J; Zhen YS; Burt ME; Faderan MA; Reardon MA
    Adv Enzyme Regul; 1982; 20():75-96. PubMed ID: 6180609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Total parenteral nutrition in a methylcholanthrene-induced rat sarcoma model.
    Popp MB; Morrison SD; Brennan MF
    Cancer Treat Rep; 1981; 65 Suppl 5():137-43. PubMed ID: 6809323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clenbuterol treatment increases muscle mass and protein content of tumor-bearing rats maintained on total parenteral nutrition.
    Chance WT; Cao LQ; Zhang FS; Foley-Nelson T; Fischer JE
    JPEN J Parenter Enteral Nutr; 1991; 15(5):530-5. PubMed ID: 1942465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of glutamine-enriched total parenteral nutrition on tumor growth and host tissues.
    Austgen TR; Dudrick PS; Sitren H; Bland KI; Copeland E; Souba WW
    Ann Surg; 1992 Feb; 215(2):107-13. PubMed ID: 1546896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor and host carcass changes during total parenteral nutrition in an anorectic rat-tumor system.
    Popp MB; Kirkemo AK; Morrison SD; Brennan MF
    Ann Surg; 1984 Feb; 199(2):205-10. PubMed ID: 6421254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of total nitrogen, asparagine, and glutamine on MCA tumor growth in the Fischer 344 rat.
    Popp MB; Enrione EB; Wagner SC; Chance WT
    Surgery; 1988 Aug; 104(2):152-60. PubMed ID: 2899915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced tissue ornithine increases the cytotoxicity of difluoromethylornithine.
    Grossie VB; Nishioka K
    Anticancer Res; 1996; 16(6B):3731-5. PubMed ID: 9042249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunostimulation following fish oil-based parenteral nutrition in tumor-bearing rats.
    Chance WT; Ogle CK; Thomas I; Zhou L; Zhang X; Basanta M; Fischer JE
    Nutr Cancer; 1996; 26(3):303-12. PubMed ID: 8910912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substituting ornithine for arginine in total parenteral nutrition eliminates enhanced tumor growth.
    Grossie VB; Nishioka K; Ajani JA; Ota DM
    J Surg Oncol; 1992 Jul; 50(3):161-7. PubMed ID: 1619938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acivicin: a new glutamine antagonist in clinical trials.
    O'Dwyer PJ; Alonso MT; Leyland-Jones B
    J Clin Oncol; 1984 Sep; 2(9):1064-71. PubMed ID: 6470756
    [No Abstract]   [Full Text] [Related]  

  • 18. Influence of total parenteral nutrition on tumor growth and polyamine biosynthesis of fibrosarcoma-bearing rats after induced cachexia.
    Grossie VB; Ota DM; Ajani JA; Chang TH; Patenia D; Nishioka K
    JPEN J Parenter Enteral Nutr; 1988; 12(5):441-4. PubMed ID: 3141639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resting and activity energy expenditure during total parenteral nutrition in rats with methylcholanthrene-induced sarcoma.
    Popp MB; Brennan MF; Morrison SD
    Cancer; 1982 Mar; 49(6):1212-20. PubMed ID: 6800630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of diabetes in the spontaneously diabetic BB rat by the glutamine antimetabolite acivicin.
    Misra M; Duguid WP; Marliss EB
    Can J Physiol Pharmacol; 1996 Feb; 74(2):163-72. PubMed ID: 8723029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.